Gülsüm Saruhan Durmaz
Gülsüm Saruhan Durmaz has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ali Onur Arzik
Department of Gynecologic Oncology, Izmir City Hospital, Izmir, Turkey
1 shared publication - Bergen Laleli Koc
Ankara City Hospital
1 shared publication - Fuat Polat
Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Educatıon Research Hospıtal, İstanbul, Turkey
1 shared publication - Güray Koç
Department of Neurology, Gulhane Training and Research Hospital, Ankara, Turkey
1 shared publication - Haşim Tüner
Department of Cardiology Istanbul Arel University Memorial Bahcelievler Hospital İstanbul Türkiye
1 shared publication - Mehmet Ali Özbek
Department of Emergency Medicine, Şırnak State Hospital, Şırnak, Türkiye
1 shared publication
Latest Publications
- Open Access
- 8 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Cardiac biomarkers combined with neuroimaging localization predict long-term outcomes in acute stroke patients
Cardiac biomarker elevation is common after stroke, but its relationship with stroke localization and long-term outcomes remains incompletely characterized. This prospective observational cohort study enrolled 695 patients (380 ischemic stroke, 135 TIA, 180 hemorrhagic stroke) from October 2020 to July 2023. High-sensitivity cardiac troponin I (hs-cTnI), NT-proBNP, and CK-MB were measured at admission and at 12–24 h. Ischemic strokes were categorized by localization (insular involvement, anterior non-insular, posterior circulation, subcortical-only). Primary outcomes were 1-year all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE). Biomarker elevations varied significantly by stroke type and localization. Hemorrhagic stroke showed the highest hs-cTnI (median 28.7 ng/L) and troponin elevation rate (54.4%). Among ischemic strokes, insular involvement demonstrated the highest biomarker levels (hs-cTnI 45.8 ng/L, NT-proBNP 892 pg/mL, troponin elevation 73.9%; all p < 0.001 versus other localizations). At 1 year, overall mortality was 20.4% and MACCE 31.4%. Elevated troponin independently predicted mortality (HR 3.24, 95% CI 2.18–4.82), MACCE (HR 2.86), and recurrent stroke (HR 1.92). A synergistic interaction between troponin elevation and insular involvement was identified for mortality (interaction HR 2.15, p = 0.029) and MACCE (interaction HR 1.84, p = 0.016). Hs-cTnI demonstrated good discriminative ability (AUC 0.782 for mortality, 0.745 for MACCE). Cardiac biomarker elevation, particularly in insular strokes, independently predicts adverse outcomes. Routine biomarker assessment combined with stroke localization data may enhance risk stratification and guide targeted interventions.
- 8 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessCardiac biomarkers combined with neuroimaging localization predict long-term outcomes in acute stroke patients
Cardiac biomarker elevation is common after stroke, but its relationship with stroke localization and long-term outcomes remains incompletely characterized. This prospective observational cohort study enrolled 695 patients (380 ischemic stroke, 135 TIA, 180 hemorrhagic stroke) from October 2020 to July 2023. High-sensitivity cardiac troponin I (hs-cTnI), NT-proBNP, and CK-MB were measured at admission and at 12–24 h. Ischemic strokes were categorized by localization (insular involvement, anterior non-insular, posterior circulation, subcortical-only). Primary outcomes were 1-year all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE). Biomarker elevations varied significantly by stroke type and localization. Hemorrhagic stroke showed the highest hs-cTnI (median 28.7 ng/L) and troponin elevation rate (54.4%). Among ischemic strokes, insular involvement demonstrated the highest biomarker levels (hs-cTnI 45.8 ng/L, NT-proBNP 892 pg/mL, troponin elevation 73.9%; all p < 0.001 versus other localizations). At 1 year, overall mortality was 20.4% and MACCE 31.4%. Elevated troponin independently predicted mortality (HR 3.24, 95% CI 2.18–4.82), MACCE (HR 2.86), and recurrent stroke (HR 1.92). A synergistic interaction between troponin elevation and insular involvement was identified for mortality (interaction HR 2.15, p = 0.029) and MACCE (interaction HR 1.84, p = 0.016). Hs-cTnI demonstrated good discriminative ability (AUC 0.782 for mortality, 0.745 for MACCE). Cardiac biomarker elevation, particularly in insular strokes, independently predicts adverse outcomes. Routine biomarker assessment combined with stroke localization data may enhance risk stratification and guide targeted interventions.
- 28 December 2021
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
- Vol. 8 (3) , 232-235
Gebelik ve Posterior Reversible Ensefalopati Sendromu: Olgu Sunumu ve Literatürün Gözden Geçirilmesi
Posterior revesible ensefalopati sendromu (PRES), nörolojik semptomlarla karakterize klinik ve radyolojik olarak geri dönüşümlü bir hastalıktır. Eklampsi, PRES’in nadir görülen nedenleri arasında yer almaktadır. Özellikle hipertansiyon ve proteinürisi olan gebelerde nöbetler görüldüğü zaman PRES ön tanıda düşünülmektedir. Hastanemize gebelik döneminde 3.trimesterde nöbet ile başvuran status epileptikus tanısı alan iki olguya sezaryen ile doğum yaptırılmış, antihipertansif ve antiepileptik tedavi verilmiştir. Bu dönemde yapılan nörolojik muayenelerinde bilinç bulanıklığı tespit edilmiş ve beyin MRG’leri PRES ile uyumlu saptanmıştır. Takiplerinde MRG lezyonları azalmış ve nöbet kontrolü sağlanmıştır. Bu yazıda eklampsi ve PRES birlikteliği olan iki olgunun sunulması ile, klinik ve radyolojik olarak PRES hastalığının literatür eşliğinde gözden geçirilmesi amaçlanmıştır.
- 28 December 2021
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
- Vol. 8 (3) , 232-235
Gebelik ve Posterior Reversible Ensefalopati Sendromu: Olgu Sunumu ve Literatürün Gözden Geçirilmesi
Posterior revesible ensefalopati sendromu (PRES), nörolojik semptomlarla karakterize klinik ve radyolojik olarak geri dönüşümlü bir hastalıktır. Eklampsi, PRES’in nadir görülen nedenleri arasında yer almaktadır. Özellikle hipertansiyon ve proteinürisi olan gebelerde nöbetler görüldüğü zaman PRES ön tanıda düşünülmektedir. Hastanemize gebelik döneminde 3.trimesterde nöbet ile başvuran status epileptikus tanısı alan iki olguya sezaryen ile doğum yaptırılmış, antihipertansif ve antiepileptik tedavi verilmiştir. Bu dönemde yapılan nörolojik muayenelerinde bilinç bulanıklığı tespit edilmiş ve beyin MRG’leri PRES ile uyumlu saptanmıştır. Takiplerinde MRG lezyonları azalmış ve nöbet kontrolü sağlanmıştır. Bu yazıda eklampsi ve PRES birlikteliği olan iki olgunun sunulması ile, klinik ve radyolojik olarak PRES hastalığının literatür eşliğinde gözden geçirilmesi amaçlanmıştır.